Drugmakers uninterested in Trump's order to split up MMR vaccine
The Hill · 36 days ago
President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three different appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive.
Continue reading at The Hill →Related
EU to Unblock €4.2 Billion for Hungary in Another Win For Magyar
Bloomberg · 6 hours ago
Centrists Won’t Tell You Where “Moderating” on Trans Rights Ends Up
The New Republic · 6 hours ago
Pete Hegseth confronts House with a lame-duck impeachment dilemma
The Hill · 6 hours ago
EU Tells Ukraine to Bolster Rule of Law Before It Gets More Aid
Bloomberg · 17 hours ago
